Skip to main content
AMNAMN Healthcare Services IncSell4.9·$33.01-1.11%
SellModerate Confidence
Investment thesis

AMN's exceptional revenue growth and solid recent earnings execution stand out, but a quality score below the required threshold, overbought momentum, and bearish insider selling warrant caution.

Thesis pillars

  • Industry Leading Revenue GrowthStable
  • Quality Below Required FloorStable
  • Overbought Momentum ConditionDeteriorating
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

AMN Healthcare Services Inc (AMN) Stock Analysis

SellVALUE-TRAP 1/5ValueModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Analyst target reached at $33.01 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings expected to decline ~65% (cyclical peak).

AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering nurse/physician/allied-health staffing, managed services programs, vendor management systems, language interpretation, and workforce technology like its WorkWise... Read more

$33.01-6.2% A.UpsideScore 4.9/10#33 of 35 Medical Care Facilities
QualityF-score5 / 9FCF yield34.48%
Stop $30.70Target $36.48(resistance)A.R:R -0.8:1
Analyst target$35.57+7.8%7 analysts
$36.48our TP
$33.01price
$35.57mean
$26
$40

Sell if holding. Analyst target reached at $33.01 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings expected to decline ~65% (cyclical peak). Chart setup: No clear chart pattern; technical signals are mixed. Score 4.9/10, moderate confidence.

Passes 5/8 gates (clean insider activity, news events none recent, earnings proximity 63d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-09-03

Recent Developments — AMN Healthcare Services Inc

Generated 2026-09-03T23:37:09Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 5, 202663d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Risks
Earnings expected to decline ~65% (cyclical peak)
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1)

Key Metrics

P/E (TTM)12.5
P/E (Fwd)35.6
Mkt Cap$1.3B
EV/EBITDA5.6
Profit Mgn3.1%
ROE15.6%
Rev Growth2.3%
Beta0.39
DividendNone
Rating analysts13

Quality Signals

Piotroski F5/9

Options Flow

P/C1.00neutral
IV64%elevated
Max Pain$45+36.3% vs spot

Concentration Risks(10-K Item 1A)

  • LOWCustomerKaiser Foundation Hospitals22%
    10-K Item 1A: 'Kaiser Foundation Hospitals (and its affiliates) (collectively, “Kaiser”) comprised approximately 22% of our consolidated revenue in 2025.'

Material Events(8-K, last 90d)

  • 2026-05-04Item 5.02LOW
    Shareholders approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan at the May 1, 2026 Annual Meeting, previously approved by the Board subject to shareholder vote. Routine compensatory plan item; no officer or director departure involved.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
4.0
Rsi
7.8
Uptrend pullback (RSI 37) - buy opportunityVolume distribution (falling OBV)Above 200-day MA

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.1
Low model confidence on this dimension (33%).
GatesMomentum 2.6<4.5A.R:R -0.8=NEGATIVEExecutive change: officer departure/appointmentInsider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 63d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
37 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $31.38Resistance $37.22

Price Targets

$31
$36
A.Upside-6.2%
A.R:R-0.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Cyclical trap - fwd PE 36x vs trail 12x (2.9x)
! Target reached (-6.2% upside)
! momentum at 2.6 (below the engine's 4.5 threshold)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-05 (63d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AMN stock a buy right now?

Sell if holding. Analyst target reached at $33.01 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings expected to decline ~65% (cyclical peak). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $30.70. Score 4.9/10, moderate confidence.

What is the AMN stock price target?

Take-profit target: $36.48 (-6.2% upside). Prior stop was $30.70. Stop-loss: $30.70.

What are the risks of investing in AMN?

Earnings expected to decline ~65% (cyclical peak); Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1).

Is AMN overvalued or undervalued?

AMN Healthcare Services Inc trades at a P/E of 12.5 (forward 35.6). TrendMatrix value score: 5.7/10. Verdict: Sell.

What do analysts say about AMN?

13 analysts cover AMN with a consensus score of 3.5/5. Average price target: $36.

What does AMN Healthcare Services Inc do?AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering...

AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering nurse/physician/allied-health staffing, managed services programs, vendor management systems, language interpretation, and workforce technology like its WorkWise platform and AMN Passport app (340,000+ users). The company had 2,664 corporate team members as of December 31, 2025 and averaged about 8,722 nurses/allied professionals in Q4 2025, with Kaiser Foundation Hospitals its largest client at approximately 22% of 2025 consolidated revenue.

Related stocks: SRTA (Strata Critical Medical, Inc.) · ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · GRDN (Guardian Pharmacy Services, Inc) · DVA (DaVita Inc.)
Home Stocks AMN

Latest news

Latest News

Benzinga20d ago
Benzinga27d agoAnalyst
Benzinga28d ago
Benzinga28d agoEarnings
Benzinga28d ago
Benzinga43d agoAnalyst